PATH
The numbers were fine. The vibes? Less so.
UiPath just turned in a mixed quarter: earnings came in at 15 cents a share, right on the Street’s nose, and revenue of $410.26 million beat estimates. Not exactly a disaster. But the market clearly wanted a little more sparkle, because the stock fell 12.4% to $15.98 the next day.
Guidance got a tiny upgrade — and that mattered
The company also bumped its fiscal 2027 revenue outlook to $1.789 billion-$1.794 billion, a hair above analyst expectations. That’s the kind of detail bulls point to and say, “See? Momentum.” But when a stock is already priced for a comeback story, “pretty good” can still land like a shrug.
Analysts started moving their goalposts
The post-earnings reaction is where this gets interesting for investors:
- Canaccord Genuity cut UiPath from Buy to Hold, even while lifting its price target from $15 to $17.
- DA Davidson kept a Neutral rating and raised its target from $12 to $16.
That combo usually means the same thing Wall Street says in a nicer suit: the business may be improving, but the easy upside is getting harder to find.
Big picture
UiPath is still trying to prove that its automation story can keep compounding without needing perfect quarterly theatrics. The market liked the revenue beat just enough to read the guidance, then quickly moved on to the next question: can this AI-automation name deliver growth that justifies the hype, or is it settling into “solid but not thrilling” territory?